News

Catch up with the latest news, press releases and announcements from the GenEdit team.

GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease

January 23, 2024/in News/by eallison

GenEdit Announces Series A1 Financing

January 17, 2024/in News/by eallison

GenEdit Is a Phase I Winner of the NIH TARGETED Challenge

December 13, 2023/in News/by eallison

Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases

February 1, 2022/in News/by Jennifer Cygan

GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021

September 23, 2021/in News/by David Anderson

GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials

September 22, 2021/in News/by David Anderson

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery

December 11, 2019/in News/by eallison